Skip to main content
Clinical Trials/NCT03426462
NCT03426462CompletedPhase 4

Time to Peak Effect of Propofol in Children

University Hospital, Basel, Switzerland1 site in 1 country48 target enrollmentStarted: April 23, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
48
Locations
1
Primary Endpoint
Time to peak effect of a propofol bolus

Study Overview

Brief Summary

In order to determine the speed of onset of the anaesthetic propofol in children, investigators will compare the two age groups 1-6 years vs 8-13 years. The primary outcome measure is the time to peak effect of a bolus of proposal, which is measured by analysing the electroencephalogram by using the permutation entropy. Further pharmacodynamic modelling will enable investigators to quantify the difference with age in the hypnotic effect of propofol.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Masking Description

The analysis of the electroencephalogram will be blinded to the age of the participant.

Eligibility Criteria

Ages
1 Year to 13 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The study population will be healthy children in the ranges of 1-6 and 8-13 years of age having surgery with American Society of Anaesthesia (ASA) grades I-II (ie. no prior functional limitation due to comorbidities) that fulfil the following points:
  • parental written consent obtained at least a day prior to begin of the subject's study episode; and
  • the child is appropriate for induction and maintenance of anaesthesia with propofol.

Exclusion Criteria

  • Any significant subject co-morbidity (ASA III or IV);
  • Withdrawal of consent/assent at any point in the study;
  • Failure to cannulate a peripheral vein prior to induction after two attempts;
  • Any other reason making IV induction with propofol impossible;
  • Allergy to propofol (or its emulsion carrier), Eutectic Mixture of Local Anesthetics (EMLA) cream or Nitrous Oxide (N2O);
  • previous enrolment in the study;
  • Any anaesthetic problem that would take precedence over completion of the study protocol.

Arms & Interventions

Age 1-6 years

Experimental

Induction of anesthesia with propofol using infusion pumps that are programmed with a pharmacokinetic model to achieve a calculated plasma concentration of the drug; this is followed by two anesthetic deepening episodes.

The target plasma concentrations achieved, as calculated by the programmed pump, is exactly the same in both age groups.

Intervention: Propofol (Drug)

Age 8-13 years

Experimental

Induction of anesthesia with propofol using infusion pumps that are programmed with a pharmacokinetic model to achieve a calculated plasma concentration of the drug; this is followed by two anesthetic deepening episodes.

The target plasma concentrations achieved, as calculated by the programmed pump, is exactly the same in both age groups.

Intervention: Propofol (Drug)

Outcomes

Primary Outcomes

Time to peak effect of a propofol bolus

Time Frame: up to 20 minutes from baseline until peak effect following second bolus administration

This is the time from the start of the propofol bolus administration to the maximal suppression of the electroencephalogram; per subject two boli will be administered

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Time to Peak Effect of Propofol in Children | Clinical Trial